Spectral Computed Tomography With Photon-counting Detector

GE Healthcare1 site in 1 country30 target enrollmentApril 19, 2021

ConditionsCT Photon-Counting

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: CT Photon-Counting
Sponsor: GE Healthcare
Enrollment: 30
Locations: 1
Primary Endpoint: Evaluate feasibility of the photon-counting CT in a clinical setting.
Status: Completed
Last Updated: 4 months ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of the study is to collect data to evaluate feasibility of the using photon-counting CT in a clinical setting.

Detailed Description

Data collected in this study includes an assessment of image quality parameters including spatial resolution, image contrast, and noise that will evaluate the product and how this photon-counting CT technology can be used to reduce the overall radiation dose in CT imaging, and enhance clinical applications for CT technology.

Registry

clinicaltrials.gov

Start Date

April 19, 2021

End Date

December 14, 2022

Last Updated

4 months ago

Study Type

Interventional

Study Design

Single Group

Sex

Male

Investigators

Sponsor

GE Healthcare

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Age \>50 years
•Normal renal function per standardized guidelines (GFR \> 60 mL/min)
•Previous CT examination at KS no more than 12 months prior to the study examination
•Signed informed consent